XORTX Therapeutics, Inc. (XRTX)
1.41
-0.44
(-23.78%)
USD |
NASDAQ |
Oct 09, 16:00
1.47
+0.06
(+4.26%)
After-Hours: 20:00
XORTX Therapeutics Free Cash Flow (Quarterly) : -3.393M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.393M |
| March 31, 2026 | -0.5052M |
| December 31, 2025 | -0.7004M |
| September 30, 2025 | -0.6403M |
| June 30, 2025 | -0.8421M |
| March 31, 2025 | -0.6471M |
| December 31, 2024 | -0.8221M |
| September 30, 2024 | -0.7721M |
| June 30, 2024 | -0.7498M |
| March 31, 2024 | -1.306M |
| December 31, 2023 | -1.307M |
| September 30, 2023 | -1.080M |
| June 30, 2023 | -1.737M |
| March 31, 2023 | -2.504M |
| December 31, 2022 | -3.814M |
| September 30, 2022 | -0.9539M |
| June 30, 2022 | -1.883M |
| Date | Value |
|---|---|
| March 31, 2022 | -2.505M |
| December 31, 2021 | -3.150M |
| September 30, 2021 | -0.0711M |
| June 30, 2021 | -0.7105M |
| March 31, 2021 | -0.9238M |
| December 31, 2020 | 0.0247M |
| September 30, 2020 | -0.0933M |
| June 30, 2020 | -0.1426M |
| March 31, 2020 | -0.3368M |
| December 31, 2019 | -0.0266M |
| September 30, 2019 | 0.0069M |
| June 30, 2019 | -0.0324M |
| March 31, 2019 | -0.0882M |
| December 31, 2018 | -0.0972M |
| September 30, 2018 | -0.1591M |
| June 30, 2018 | -0.2132M |
| March 31, 2018 | -0.279M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -1.661M |
| InMed Pharmaceuticals, Inc. | -2.909M |
| Target Group, Inc. (Canada) | -0.2294M |
| NervGen Pharma Corp. | -4.086M |
| Milestone Pharmaceuticals, Inc. | -22.56M |